CASI Pharmaceuticals (CASI) 10-K2021 FY Annual report

Filed: 28 Mar 22, 9:53am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: adapt, adherence, AEs, AHFCA, AHFCAA, Alesta, allied, appeal, Barcelona, BioHealth, broker, Bulletin, burden, channel, charter, CID, clarify, Communist, compound, constantly, contemplate, CRPCGIT, cure, cytotoxic, decree, depth, detention, disgorgement, DRR, EMA, esteve, expend, forfeiture, FPI, France, geopolitical, great, Hainan, headcount, HFCA, HFCAA, ID, IMCT, imposition, improperly, indefinite, intention, led, linkage, logo, mantle, manufactory, marginal, mentioned, mutual, NADA, notify, notifying, official, ot, OTC, passage, payroll, PMS, prevalence, regime, remodeling, repaid, repurchase, repurchased, restitution, restore, reveal, Senate, Tech, unconditional, untitled, Unused, volitality, voluntarily, voluntary, warning, Wining, withdrawn, ZhongBio

Removed: Accreditation, administering, adult, ancillary, AQSIQ, assessed, attend, binding, CAC, capitalize, circumvention, claiming, classification, commit, composition, conceived, consistency, convincing, CRGK, Cynthia, deliver, delivered, desirable, devotion, discovered, Door, employed, engineering, enjoin, EntreMed, equivalence, extremely, favor, forward, Hu, IMCCT, infringe, inherently, interpreting, invalidation, invited, largely, leave, massive, meaningfully, message, microtubule, modification, Navigating, originator, outsource, patenting, Ph, Philadelphia, placement, practical, prepare, prevail, principally, progressed, quarantine, radiotherapeutic, reducing, refocused, regained, reject, relapse, renew, reorganization, retail, retrospective, revoked, routine, SAC, SAIC, secret, secured, shortage, Standardization, sweeping, undertaken, unfamiliar, uniform, unpatented, vest, wave

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CASI transcripts

CASI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (No. 333-101617, 333-222043, 333-228980, 333-188042 and 333-258819) on Form S-8 and the registration statements (No. 333-80193, 333-84907, 333-76824, 333-104380, 333-110604, 333-122309, 333-133190, 333-132715, 333-151542, 333-167754, 333-182803, 333-200927, 333-214889, 333-222701, 333-226206, 333-228383 and 333- 250801) on Form S-3 of our report dated March 28, 2022, with respect to the consolidated financial statements of CASI Pharmaceuticals, Inc..

/s/ KPMG Huazhen LLP

Beijing, China

March 28, 2022